GHRS - GH Research

-

$undefined

N/A

(N/A)

GH Research NASDAQ:GHRS GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression.

Location: 28 Baggot Street, Leinster, D02 NX43, Ireland | Website: www.ghres.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

281.3M

Cash

151.3M

Avg Qtr Burn

-9.489M

Short % of Float

22.98%

Insider Ownership

40.39%

Institutional Own.

58.95%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.